These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35532929)

  • 21. Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid.
    Bui LM; Taubeneck MW; Commisso JF; Uriu-Hare JY; Faber WD; Keen CL
    Toxicology; 1998 Feb; 126(1):9-21. PubMed ID: 9585088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel human pluripotent stem cell-based assay to predict developmental toxicity.
    Lauschke K; Rosenmai AK; Meiser I; Neubauer JC; Schmidt K; Rasmussen MA; Holst B; Taxvig C; Emnéus JK; Vinggaard AM
    Arch Toxicol; 2020 Nov; 94(11):3831-3846. PubMed ID: 32700165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture.
    Lewandowski C; Klug S; Nau H; Neubert D
    Arch Toxicol; 1986 Apr; 58(4):239-42. PubMed ID: 3087328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
    Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
    Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
    Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
    Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociceptive changes in rats after prenatal exposure to valproic acid.
    Schneider T; Labuz D; Przewłocki R
    Pol J Pharmacol; 2001; 53(5):531-4. PubMed ID: 11990073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.
    Conner TM; Nikolian VC; Georgoff PE; Pai MP; Alam HB; Sun D; Reed RC; Zhang T
    Eur J Pharm Sci; 2018 Jan; 111():465-481. PubMed ID: 29030176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
    Andrews JE; Ebron-McCoy MT; Bojic U; Nau H; Kavlock RJ
    Teratology; 1997 May; 55(5):314-8. PubMed ID: 9261925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified Xenopus laevis approach (R-FETAX) as an alternative test for the evaluation of foetal valproate spectrum disorder.
    Battistoni M; Bacchetta R; Di Renzo F; Metruccio F; Moretto A; Menegola E
    Reprod Toxicol; 2022 Jan; 107():140-149. PubMed ID: 34923091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of read-across and artificial neural network-based QSAR models for predicting systemic toxicity: A case study for valproic acid.
    Hisaki T; Kaneko MAN; Hirota M; Matsuoka M; Kouzuki H
    J Toxicol Sci; 2020; 45(2):95-108. PubMed ID: 32062621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of High-Throughput Model Parameterization and Data Uncertainty on Thyroid-Based Toxicological Estimates for Pesticide Chemicals.
    Carlson JM; Janulewicz PA; Kleinstreuer NC; Heiger-Bernays W
    Environ Sci Technol; 2022 May; 56(9):5620-5631. PubMed ID: 35446564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory-cued sensorimotor task reveals disengagement deficits in rats exposed to the autism-associated teratogen valproic acid.
    Chomiak T; Hung J; Cihal A; Dhaliwal J; Baghdadwala MI; Dzwonek A; Podgorny P; Hu B
    Neuroscience; 2014 May; 268():212-20. PubMed ID: 24631679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
    Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a generic zebrafish embryo PBPK model and application to the developmental toxicity assessment of valproic acid analogs.
    Siméon S; Brotzmann K; Fisher C; Gardner I; Silvester S; Maclennan R; Walker P; Braunbeck T; Bois FY
    Reprod Toxicol; 2020 Apr; 93():219-229. PubMed ID: 32114065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats.
    Vorhees CV
    Psychopharmacology (Berl); 1987; 92(2):173-9. PubMed ID: 3110838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative In Vitro-to-In Vivo Extrapolation for Mixtures: A Case Study of Superfund Priority List Pesticides.
    Valdiviezo A; Luo YS; Chen Z; Chiu WA; Rusyn I
    Toxicol Sci; 2021 Aug; 183(1):60-69. PubMed ID: 34142158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and Optimization of Pharmacokinetic Models for
    Casey WM; Chang X; Allen DG; Ceger PC; Choksi NY; Hsieh JH; Wetmore BA; Ferguson SS; DeVito MJ; Sprankle CS; Kleinstreuer NC
    Environ Health Perspect; 2018 Sep; 126(9):97001. PubMed ID: 30192161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.